Introduction
Investigation of inborn errors affecting folate metabolism have demonstrated that a chronic, severe central nervous system deficiency of 5-methyltetrahydrofolate (5MTHF) leads to neurological disease (1, 2) . It is currently unclear whether more subtle changes in folate status may affect neurological function. This may be particularly relevant in young children where brain growth is rapid and demand for folates is high. In order to investigate this possibility it is necessary to have Paediatric ranges and a reliable assay for 5MTHF, this being the major form of folate found in plasma and cerebrospinal fluid (CSF) (3). A simple assay based on HPLC separation followed by coulometric electrochemical detection of CSF 5MTHF has therefore been developed and validated by comparison against an assay using L. casei. Reference ranges for CSF 5MTHF have also been established.
Material and Methods

Chemicals
5MTHF was from Sigma (St. Louis MO, USA). Methanol was from Baxter (Illinois, USA). All other chemicals were of Analar grade.
Apparatus
The chromatographic system consisted of a Spectra Physics Isochrom pump (San Jose, CA, USA), a Rheodyne "152 injector (Cotati. CA. USA), Spheri-" Author to whex. : rr-e-r^ndence should be addressed. sorb 5 μΜ ODS (25 χ 0.45 cm ID) reversed phase column (Phase Separations Inc., Connecticut, USA) protected by a 5 μΜ ODS guard column (1 χ 0.45 cm ID) (Upchurch, Oak Harbour WA, USA). Detection was by an ESA Coulochem 5100A electrochemical detector using the first electrode of a model 5010 dual cell analytical electrode set at + 0.05V (Bedford, MA, USA). Peak areas were determined using a Spectra Physics Chromjet integrator.
Mobile phase
The mobile phase consisted of sodium acetate (60 mmol/1) pH 4.6, containng EDTA (48 μιηοΐ/l) and methanol (160 ml/1). This was degassed before use with helium. The flow rate was 1.3 ml/min and the column temperature was maintained at 30 ' C.
Sample collection and standard preparation
Lumber CSF was collected in 0.5 ml aliquots and frozen on dry ice at the bedside. The seventh aliquot was used for the analysis of 5MTHF. Samples were stored at -70 C until analysed. A 100 nmol/1 standard solution of 5MTHF was prepared in H 2 0 containing 0.1% ascorbic acid. Samples of standard or CSF (20 μΐ) were injected either manually or by the use of a refrigerated autosampler (Spectra Physics).
Results and Discussion
The very low potential required for the oxidation of 5MTHF allowed for the direct injection of CSF without sample cleanup. Injection of standard or CSF Ptendine? Copyright produced a single peak having a retention time of less than 5 minutes (Fig. 1) . No further peaks were detected after this period which allowed for rapid analysis of samples. 5MTHF remained stable within CSF at 5 °C for up to 12 hours therefore allowing for automated analysis using a refrigerated autosampler. The within day and between day coefficients of variation were both less than 8% and the assay was linear up to at least 20 pmol injected with the lower limit of detection being 20 fmol. This low limit would allow for the detection of 1 nmol/1 of 5MTHF in CSF which was below the very low levels (4 nmol/1) found in a patient with 5,10-methylenetetrahydrofolate reductase deficiency (Fig. 1) .
A.
B. Hydrodynamic voltamograms obtained from the standard and CSF were essentially identical (not shown) demonstrating that the peak detected in CSF was not contaminated with other oxidizable compounds. Further validation of the current method was achieved by comparing the HPLC results with those found following analysis of the same samples using L. casei. A linear relationship was found between the two methods (R = 0.876, η = 36, ρ < 0.001) (Fig. 2) . In summary the present assay provides a simple and specific assay for CSF 5MTHF which is not affected by anti-metabolites such as methotrexate. The availability of reference ranges will be of importance for the determination of central nervous system folate deficiency in paediatric neurological disease.
